Glaxosmithkline sec filings
WebApr 10, 2024 · Mon., April 10, 2024 MarketBeat MONECO Advisors LLC bought a new position in shares of GSK plc ( NYSE:GSK - Get Rating) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 6,494 shares of the pharmaceutical company's stock, valued at approximately $228,000. WebMar 29, 2024 · Naples Global Advisors LLC lifted its stake in shares of GSK plc (NYSE:GSK - Get Rating) by 8.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 44,304 shares of the pharmaceutical company's stock after acquiring an addition
Glaxosmithkline sec filings
Did you know?
WebApr 6, 2024 · GSK plc (GSK) - 6-K - Report of Foreign Issuer. SEC FilingsFri, Mar. 24. WebGlaxoSmithKline PLC ADR SEC filings breakout by MarketWatch. View the GSK U.S. Securities and Exchange Commission reporting information.
WebGlobal leader 100% focused on consumer healthcare with clear purpose to deliver better everyday health with humanity Exceptional portfolio of category leading brands with attractive footprint and competitive capabilities WebGSK
WebSEC Filings are formal documents required by the government that describe the financial health and operating activities for any company that has publicly traded stock. The reports can be viewed or downloaded using your web browser (HTML), a Microsoft Word document, an Adobe PDF, or as an Excel spreadsheet. Types of filings include: WebJun 11, 2007 · GlaxoSmithKline PLC Securities Litigation Case Status: DISMISSED On or around 05/13/2008 (Date of order of final judgment) Filing Date: June 11, 2007 On September 04, 2008, a notice of appeal was filed by the Plaintiffs. On October 10, 2008, a mandate was made withdrawing the notice of appeal.
WebJan 17, 2024 · Gsk Plc (GSK) SEC Filing 6-K Foreign Issuer Report for the period ending Tuesday, January 17, 2024. ... SEC Filings. GSK Valuations. Intrinsic Value. Financial …
WebAug 27, 2024 · CARLSBAD, Calif., Aug. 27, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in RNA-targeted therapeutics, announced today that GSK exercised its option to license Ionis' antisense medicines for people with chronic hepatitis B virus (CHB) infection following positive Phase 2 results. dj dash uciha plis ku tak suka slow remixWebJan 1, 2024 · Following any tender or exchange offer for stock of GlaxoSmithKline p.l.c., the decision to tender with respect to all such securities shall be exercised by Participants. The Company shall use its best efforts to provide each Participant with communications and instruction forms for the tender of shares allocated to the Participant’s Account. dj dash uciha preman slowWebApr 14, 2024 · International Assets Investment Management LLC bought a new stake in GSK plc (NYSE:GSK - Get Rating) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 12,199 shares of the pharmaceutical company's stock, valued at approxima dj daronWebMar 10, 2024 · Analyze up to 10 years of full 10K Annual Reports and Quarterly 10Q SEC filings for Glaxosmithkline Plc (GSK) using our … dj dash uciha preman slow remixWebMar 20, 2024 · GLAXOSMITHKLINE PLC (Filer) CIK: 0001131399 (see all company filings) IRS No.: 000000000 State of Incorp.: X0 Type: 20-F/A Act: 34 File No.: 001-15170 … dj dashgodWebMar 20, 2024 · SEC Home » Search the Next ... GLAXOSMITHKLINE PLC (Filer) CIK: 0001131399 (see all company filings) IRS No.: 000000000 State of Incorp.: X0 Type: 20-F/A Act: 34 File No.: 001-15170 Film No.: 18700645 SIC: 2834 Pharmaceutical Preparations Office of Life Sciences ... dj datzWebDownload our 2024 Annual Report and ESG Performance Report. Annual Report 2024 (PDF - 15.0MB) ESG Performance Report 2024 (PDF - 1.2MB) Cautionary statement (PDF - 66.1KB) Annual Report 2024 (iXBRL Viewer) Annual Report 2024 ESEF (ESEF reporting package) (ZIP - 13.5MB) 20-F 2024 (PDF - 4.1MB) dj databaze